Protein kinase inhibitor H-7
CAS No. 84477-87-2
Protein kinase inhibitor H-7( -(5-Isoquinolinylsulfonyl)-2-methylpiperazine | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline )
Catalog No. M28552 CAS No. 84477-87-2
Protein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 78 | Get Quote |
|
| 25MG | 123 | Get Quote |
|
| 50MG | 176 | Get Quote |
|
| 100MG | 257 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameProtein kinase inhibitor H-7
-
NoteResearch use only, not for human use.
-
Brief DescriptionProtein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.
-
DescriptionProtein kinase inhibitor H-7 is a potent inhibitor of protein kinase C (PKC) with a Ki of 6 μM. Protein kinase inhibitor H-7 is also a cyclic nucleotide dependent protein kinase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms-(5-Isoquinolinylsulfonyl)-2-methylpiperazine | 5-(2-methylpiperazine-1-sulfonyl)isoquinoline
-
PathwayAngiogenesis
-
TargetPKC
-
RecptorSmoothened
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number84477-87-2
-
Formula Weight291.37
-
Molecular FormulaC14H17N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (343.21 mM)
-
SMILESO=S(=O)(C1=CC=CC=2C=NC=CC21)N3CCNCC3C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Y, et al. Selective identification of hedgehog pathway antagonists by direct analysis of smoothened ciliary translocation. ACS Chem Biol. 2012 Jun 15;7(6):1040-8.
molnova catalog
related products
-
UCN-01
UCN-01 (7-Hydroxystaurosporine;NSC 638850) is a synthetic derivative of staurosporine that has antiproliferative activity against several in vitro and in vivo cancer models.
-
Hypocrellin A
Hypocrellin A is PKC inhibitor has light-induced antitumorantifungal and antiviral activities it also exerts immunomodulatory effects on MHC-restricted presentation of antigen.
-
Ruboxistaurin hydroc...
A potent, selective, ATP-competitive, orally available PKC beta (PKCβ) inhibitor with IC50 of 4.7 and 5.9 nM for PKCβ I and PKCβ II, respectively.
Cart
sales@molnova.com